Ibisobanuro
Methyl 2-mikorerexy-4-aminobenzoate nintera yingenzi mugukora lenvatinib, ikoreshwa mukuvura kanseri ya tiroyide nimpyiko.Uru ruganda ruciriritse rufite uruhare runini mu nganda zimiti kuko aribikoresho byibanze bya synthesis ya lenvatinib.
Urusange, rufite CAS numero 27492-84-8, ruzwiho ubuziranenge no kwizerwa.Yakozwe hifashishijwe ikoranabuhanga rigezweho hamwe ningamba zikomeye zo kugenzura ubuziranenge kugirango irebe ko yujuje ubuziranenge bw’inganda.Lenvatinib yacu hagati ya 2-mikorerexy-4-aminobenzoic aside methyl ester iraboneka mubice kandi irakwiriye kubyara imiti nini.
Methyl yacu 2-mikorerexy-4-aminobenzoate ni ifu yera-yera-ifu ya kristaline ifata byoroshye mumashanyarazi.Ifite porogaramu nyinshi mu nganda zimiti kandi izwiho ubuziranenge budasanzwe no guhagarara neza.Uru ruganda rupakiwe neza kugirango rwemeze ubunyangamugayo mugihe cyo kubika no kohereza, bituma abakiriya bacu bashingira ku bwiza bwarwo.
Hitamo
JDK ifite ibikoresho byo mu rwego rwa mbere n’ibikoresho byo gucunga ubuziranenge, byizeza itangwa rihamye ry’abahuza API.Itsinda ry'umwuga ryizeza R&D y'ibicuruzwa.Kurwanya byombi, turimo gushakisha CMO & CDMO kumasoko yimbere mu gihugu no mumahanga.
